Celentyx Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • 2ndary - Private

Celentyx General Information

Description

Provider of human immune cell assay services intended to understand the effect of small molecules and biological candidates on the human immune system. The company offers an analysis of drug action on human immune cells, bolsters the progression of immuno-oncology therapies, provides access to patient and healthy donor samples for in-depth analysis, and accelerates therapeutic discoveries in immunology, enabling physicians to detect the human system at the levels of resolution.

Contact Information

Formerly Known As
Gordons79
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Birmingham Research Park
  • 97 Vincent Drive
  • Birmingham B15 2SQ
  • England, United Kingdom
+44 0121
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Vertical(s)
Corporate Office
  • Birmingham Research Park
  • 97 Vincent Drive
  • Birmingham B15 2SQ
  • England, United Kingdom
+44 0121

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celentyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Feb-2021 Completed Generating Revenue
5. Grant 01-Jan-2021 Completed Generating Revenue
4. Early Stage VC 12-Dec-2007 Completed Generating Revenue
3. Grant 13-Dec-2006 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2004 Completed Startup
To view Celentyx’s complete valuation and funding history, request access »

Celentyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 1
Ordinary
To view Celentyx’s complete cap table history, request access »

Celentyx Patents

Celentyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2009502768-A Acupuncture Inactive 22-Jul-2005
AU-2006271377-A1 Novel epilepsy treatment Inactive 22-Jul-2005
CA-2616141-A1 Novel epilepsy treatment Inactive 22-Jul-2005
EP-1906959-A1 Novel epilepsy treatment Inactive 22-Jul-2005
GB-0515090-D0 Novel epilepsy treatment Inactive 22-Jul-2005 A61K31/46
To view Celentyx’s complete patent history, request access »

Celentyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celentyx FAQs

  • When was Celentyx founded?

    Celentyx was founded in 2004.

  • Where is Celentyx headquartered?

    Celentyx is headquartered in Birmingham, United Kingdom.

  • What is the size of Celentyx?

    Celentyx has 13 total employees.

  • What industry is Celentyx in?

    Celentyx’s primary industry is Drug Discovery.

  • Is Celentyx a private or public company?

    Celentyx is a Private company.

  • What is Celentyx’s current revenue?

    The current revenue for Celentyx is .

  • How much funding has Celentyx raised over time?

    Celentyx has raised $121K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process